Form 8-K - Current report:
SEC Accession No. 0001628280-24-012633
Filing Date
2024-03-22
Accepted
2024-03-21 20:22:01
Documents
33
Period of Report
2024-03-21
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lenz-20240321.htm   iXBRL 8-K 396011
2 EX-3.1 exhibit31-super8xk.htm EX-3.1 45277
3 EX-10.6 exhibit106-super8xk.htm EX-10.6 80011
4 EX-10.7 exhibit107-super8xk.htm EX-10.7 111874
5 EX-10.8 exhibit108-super8xk.htm EX-10.8 47641
6 EX-10.9 exhibit109-super8xk.htm EX-10.9 396240
7 EX-10.10 exhibit1010-super8xk.htm EX-10.10 165392
8 EX-10.11 exhibit1011-super8xk.htm EX-10.11 33652
9 EX-10.12 exhibit1012-super8xk.htm EX-10.12 35186
10 EX-10.13 exhibit1013-super8xk.htm EX-10.13 34345
11 EX-10.14 exhibit1014-super8xk.htm EX-10.14 31894
12 EX-10.16 exhibit1016-super8xk.htm EX-10.16 36405
13 EX-10.21 exhibit1021-super8xk.htm EX-10.21 185247
14 EX-16.1 exhibit161-super8xk.htm EX-16.1 3529
15 EX-23.1 exhibit231-super8xk.htm EX-23.1 3220
16 EX-99.1 exhibit991-super8xk.htm EX-99.1 469116
17 EX-99.2 exhibit992-super8xk.htm EX-99.2 226173
18 EX-99.3 exhibit993-super8xk.htm EX-99.3 23188
23 exhibit9931aa.jpg GRAPHIC 11564
24 lenz-20240321_g1.jpg GRAPHIC 96289
  Complete submission text file 0001628280-24-012633.txt   3137475

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lenz-20240321.xsd EX-101.SCH 2143
20 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lenz-20240321_def.xml EX-101.DEF 16421
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lenz-20240321_lab.xml EX-101.LAB 29036
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lenz-20240321_pre.xml EX-101.PRE 17247
36 EXTRACTED XBRL INSTANCE DOCUMENT lenz-20240321_htm.xml XML 4017
Mailing Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014
Business Address 445 MARINE VIEW AVE SUITE 320 DEL MAR CA 92014 858-925-7000
LENZ Therapeutics, Inc. (Filer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40532 | Film No.: 24772814
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)